On 23 February, Aeterna Zentaris Inc. (NASDAQ: AEZS) announced that it has started promoting APIFINY®, the only cancer specific, non-PSA blood test for the evaluation of the risk of prostate cancer, in 20 U.S. territories pursuant to its co-marketing agreement with Armune BioScience, Inc.
Aeterna Zentaris Inc. (NASDAQ:AEZS) belongs to Healthcare sector. Its weekly performance is 0.32%. On last trading day company shares ended up at $3.12.
Rice Midstream Partners LP (NYSE:RMP) reported Fourth quarter average daily throughput of 703 MDth/d, a 36% increase relative to fourth quarter 2014. 2015 average daily throughput of 647 MDth/d, a 71% increase relative to full-year 2014 volumes. Adjusted EBITDA of $19.1 million and $63.8 million for the fourth quarter and full-year, respectively.
Rice Midstream Partners LP (NYSE:RMP) shares moved up 7.08% in last trading session and ended the day at $12.85. RMP Gross Margin is 99.00% and its return on assets is 13.40%. Rice Midstream Partners LP (NYSE:RMP) quarterly performance is -5.52%.
Merck & Co. Inc. (NYSE: MRK) announced top-line results from the company’s Phase 3 pivotal trial, ONCEMRK. ONCEMRK is evaluating an investigational once-daily formulation of ISENTRESS (raltegravir), known as raltegravir 600 mg (to be given as 2 x 600 mg once-daily), for previously untreated HIV-1 infected adults. The study met its primary efficacy endpoint: 1200 mg raltegravir (given as 2 x 600 mg once-daily) was statistically non-inferior to the marketed formulation approved dose of ISENTRESS 400 mg twice-daily, each in combination therapy with TRUVADA™, as assessed by the proportion of patients achieving HIV-1 RNA <40 copies/mL at Week 48. On 25 February, Merck & Co. Inc. (NYSE:MRK) shares moved up 0.87% and was closed at $51.00. MRK EPS growth in last 5 year was -6.30%. Merck & Co. Inc. (NYSE:MRK) year to date (YTD) performance is -3.45%. On 10 February, ACCO Brands Corporation (NYSE:ACCO) reported Net sales decreased 10% to $412.1 million from $459.9 million in the prior-year quarter. On a constant currency basis, sales decreased 2%, driven primarily by the International segment. Operating income decreased to $56.9 million from $68.5 million in the prior year, primarily due to a $6.1 million impact from foreign currency translation. ACCO Brands Corporation (NYSE:ACCO) ended the last trading day at $7.19. Company weekly volatility is calculated as 2.63% and price to cash ratio as 13.81. ACCO Brands Corporation (NYSE:ACCO) showed a weekly performance of 0.42%. Innodata Inc. (NASDAQ:INOD) reported Total revenue was $15.5 million in the fourth quarter of 2015, a 3% sequential increase from $15.1 million in the third quarter of 2015 and an approximately 2% decline from $15.9 million in the fourth quarter of 2014. Innodata Inc. (NASDAQ:INOD) shares moved down -0.42% in last trading session and ended the day at $2.36. INOD Gross Margin is 25.00% and its return on assets is -4.70%. Innodata Inc. (NASDAQ:INOD) quarterly performance is -6.72%.